TN HB1984

The Use Of Buprenorphine Products

Passed House Timothy Hill (R)
Plain English Summary

Tennessee HB1984 allows more healthcare providers to give patients buprenorphine, a medication used to treat opioid addiction, without needing naloxone, a drug that can reverse overdoses. It also clarifies that prescribing buprenorphine to nursing mothers or injectable forms does not limit healthcare providers from prescribing it for opioid use disorder treatment.

Supporters Say

Supporters of HB1984 argue that this legislation expands access to critical treatment for those struggling with opioid addiction, potentially saving lives by allowing more healthcare professionals to administer effective medications. They believe it will improve the overall health outcomes for patients and support families affected by addiction.

Critics Say

Critics of HB1984 may express concerns about the potential risks of administering buprenorphine without naloxone, arguing that it could lead to increased overdoses if not properly managed. They might also worry that the expansion of prescribing authority could result in misuse or over-prescription of the medication.

Conflict of Interest Analysis Personal Interests
2/10
Risk Level
Low
Policy Area
Health
Industry Overlap
0%
Personal Conflicts
0 found

The analysis of Representative Timothy Hill's personal financial interests reveals no direct conflicts with the subject matter of HB1984. The bill pertains to the regulation of buprenorphine products, which are used in the treatment of opioid use disorder. Representative Hill's financial interests are primarily in marketing, media, and unrelated biomedical sectors. Although he is the CEO of LIFECO BIOMED, a company that could potentially be involved in the broader biomedical field, there is no evidence to suggest that this company is directly involved in the production or distribution of buprenorphine products. Therefore, the risk of a conflict of interest is low, as there is no direct alignment between his financial interests and the bill's impact on the healthcare or pharmaceutical sectors.

Sponsor's Personal Financial Interests

Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.

Type Description Industry Source
Occupation Public Relations Consultant Misc Business AI-researched
Employer Owner of Right Way Marketing AI-researched
Business Owner Owner of Right Way Marketing AI-researched
Employer RIGHT WAY MARKETING, LLC TN Ethics Commission
Employer APPALACHIAN RADIO GROUP TN Ethics Commission
Employer UPSTREAM BIO Misc Transport TN Ethics Commission
Employer SUPPLY MUNITION LLC TN Ethics Commission
Business Owner LIFECO BIOMED CHIEF EXECUTIVE OFFICER from Jan 2023 to current TN Ethics Commission
Business Owner APPALACHIAN EDUCATIONAL COMMUNICATIONS CORPORATION SECRETARY from Aug 2025 to current TN Ethics Commission
Asset SUPPLY MUNITIONS, LLC TN Ethics Commission
Asset LIFECO BIOMED TN Ethics Commission
Asset DYNE THERAPEUTICS TN Ethics Commission
Asset BROADCAST PARTNERS TN Ethics Commission
Asset Leadership PAC: PEOPLE WORKING FOR REFORM PAC- PWR PAC- NO LONGER ACTIVE TN Ethics Commission

Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.